2-{4-[1-(4-iodobenzoyl)-1H-pyrazol-3-yl]phenoxy}pyrimidine

Catalog No. :
ACXNOV120
CAS No. :
321998-85-0
Molecular Formula :
C20H13IN4O2
Molecular Weight :
468.25

IUPAC Name:(4-iodophenyl)(3-(4-(pyrimidin-2-yloxy)phenyl)-1H-pyrazol-1-yl)methanone

2-{4-[1-(4-iodobenzoyl)-1H-pyrazol-3-yl]phenoxy}pyrimidine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g90%$284.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2-{4-[1-(4-iodobenzoyl)-1H-pyrazol-3-yl]phenoxy}pyrimidine
IUPAC Name(4-iodophenyl)(3-(4-(pyrimidin-2-yloxy)phenyl)-1H-pyrazol-1-yl)methanone
MDL No.MFCD01443807
Molecular FormulaC20H13IN4O2
Molecular Weight468.25
SMILESO=C(N1N=C(C2=CC=C(OC3=NC=CC=N3)C=C2)C=C1)C4=CC=C(I)C=C4
InChI KeyRVTXJKKUCJILNJ-UHFFFAOYSA-N
Synonym(4-IODOPHENYL)(3-[4-(2-PYRIMIDINYLOXY)PHENYL]-1H-PYRAZOL-1-YL)METHANONE;2-{4-[1-(4-iodobenzoyl)-1H-pyrazol-3-yl]phenoxy}pyrimidine;Methanone, (4-iodophenyl)[3-[4-(2-pyrimidinyloxy)phenyl]-1H-pyrazol-1-yl]-
CAS No.321998-85-0

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P330-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACXNOV120 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACXNOV120 route product structure diagram
    ACXNOV120321998-85-0
Inquiry

2. ACXNOV120 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACNKTZ369 route compound structure diagram
    ACNKTZ3691722-12-9 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACXNOV120 route product structure diagram
    ACXNOV120321998-85-0
Inquiry

Comments (0)